Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
血吸虫肺动脉高压中 CD4 T 细胞的激活、表型和功能
基本信息
- 批准号:10897448
- 负责人:
- 金额:$ 8.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-15 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAmplifiersAnimal ModelAntigen PresentationAntigensAreaAutoimmune DiseasesAutomobile DrivingBloodBlood VesselsBlood specimenBrazilCCL2 geneCCL7 geneCD4 Positive T LymphocytesCardiac Catheterization ProceduresCellsCirculationClinicalCommunicable DiseasesCountryDendritic CellsDevelopmentDiagnosisDiagnostic testsDiseaseEchocardiographyEquilibriumEventExposure toFoundationsFractalkineFutureHelminthsHumanHypoxiaITGAM geneImmuneImmune ToleranceImmune systemIndividualInflammationInflammatoryInterleukin-1LigandsLungMacrophageModelingMusNatural ImmunityParasitesParasitic infectionPathogenesisPathologyPatientsPhenotypePlasmaPlasma ProteinsPopulationPopulations at RiskPredispositionProteinsPublic HealthPulmonary HypertensionResource-limited settingRiskRoleSU 5416SchistosomaSchistosomiasisSeriesSourceSpecimenSterilityT-Cell ActivationTestingThrombospondin 1Transforming Growth Factor betaVaccinesVascular DiseasesVascular remodelingWorkadaptive immunitycell typeclinical centercohortcross immunitycytokinediagnostic biomarkerdisease diagnosisexperimental studyinterstitialmonocytemouse modelnovel diagnosticsnovel strategiespreventpulmonary arterial hypertensionpulmonary vascular disorderrecruitscreeningvascular inflammation
项目摘要
Summary/Abstract
Inflammation has important roles in the pathogenesis of pulmonary arterial hypertension (PAH), but whether
inflammation is causal, an amplifier of alternative triggering mechanisms, or an epiphenomenon remains unclear.
Prior studies in this area have largely focused on innate immunity, sterile models, and single cytokines or cells
in the absence of a well-defined pathobiological context—approaches that cannot address aspects of adaptive
immunity or innate-adaptive immunity crosstalk which contribute to vascular disease. To address these
limitations, our group studies the parasite Schistosoma, the cause of schistosomiasis which may be the most
prevalent form of PAH worldwide. Using a Schistosoma-pulmonary hypertension (PH) murine model, studies in
the prior period identified a series of mechanistic events which are critical for PH development: Th2-activation of
CD4 T cells in the lungs; which recruit of CCR2+ Ly6c+ monocytes to the adventitial space that express
thrombospondin-1 (TSP-1); and the TSP-1 functionally activates latent TGF-β, causing vascular remodeling.
This proposal builds on this foundation by now interrogating adaptive and innate immune interfaces that we
believe to be necessary to Schistosoma-PH pathogenesis. We extend our studies to translational analysis of
human biospecimens, seeking proteins that correlate with PAH presence in an at-risk group with severe
schistosomiasis. This proposal will test the hypothesis that intrapulmonary dendritic cells (DCs) present
Schistosoma antigen to CD4 T cells which support Th2 polarization, causing activation of interstitial
macrophages (IMs), who release the CCR2 ligands CCLs 2, 7 and 12, driving TSP-1+ monocyte recruitment,
TGF-β activation, and PH. We also hypothesize that key proteins that increase risk of PAH—including CCL2,
CCL7, CCL12, and TSP-1—can be detected in human plasma. We propose 4 Aims. Aim 1 will determine that
antigen presentation by a specific DC subset, cDC2s, is required for T cell activation in Schistosoma-PH. Aim 2
will determine if the balance of Th1 to Th2 inflammation drives monocyte/macrophage and PH phenotypes in
Schistosoma-PH. Aim 3 will determine that CCL2/7/12 release by IMs is required for TSP1+ monocyte
recruitment in Schistosoma-PH. Aim 4 will identify plasma proteins associated with PAH development in subjects
with schistosomiasis. This translational Aim will be achieved by developing and characterizing two cohorts of
subjects recruited from 4 clinical centers in Brazil: subjects with the precursor condition schistosomiasis
hepatosplenic disease (SchHSD) who are unlikely to have PAH on the basis of echocardiography screening,
and subjects with SchHSD who have right heart catheterization-confirmed PAH. Completion of these studies will
lead to understanding the role of innate and adaptive immunity in the development of Schistosoma-PAH, and
create opportunities for entirely novel approaches to diagnosing and potentially treating this disease. We propose
to identify mechanistic proteins which correlate with disease presence in blood, facilitating screening of at-risk
subjects in low-resource areas.
摘要/摘要
炎症在肺动脉高压(PAH)的发病机理中具有重要作用,但是是否是否
炎症是因果关系,是替代触发机制的放大器,或者epiphenomenon尚不清楚。
该领域的先前研究主要集中于先天免疫,无菌模型和单细胞因子或细胞
在没有明确定义的病理学环境的情况下 - 无法解决适应性方面
免疫或先天自适应免疫串扰,导致血管疾病。解决这些
局限性,我们的小组研究了寄生虫血吸虫,这是血吸虫病的原因,这可能是最多的
全球PAH的普遍形式。使用肺肺血吸虫高血压(pH)鼠模型,研究
前期确定了一系列对于pH发展至关重要的机械事件:Th2激活
肺中的CD4 T细胞; CCR2+ LY6C+单核细胞的招募到表达的冒险空间
血小板传播1(TSP-1); TSP-1在功能上激活潜在的TGF-β,导致血管重塑。
这项建议基于这个基础,现在询问我们的适应性和先天免疫接口
认为是血吸虫 - ph发病机理所必需的。我们将研究扩展到翻译分析
人类生物测量,寻求与PAH存在相关的蛋白质
血吸虫病。该提案将检验以下假设:肺内树突状细胞(DC)
对支持Th2极化的CD4 T细胞的抗原,导致间质激活
释放CCR2配体CCLS 2、7和12的巨噬细胞(IMS),驱动TSP-1+单核细胞募集,
TGF-β激活和pH。我们还假设关键蛋白质会增加PAH风险 - 包括CCL2,
CCL7,CCL12和TSP-1-可以在人血浆中检测到。我们提出了4个目标。 AIM 1将确定
特异性DC子集Cdc2s的抗原表现是Scistosoma-PH中T细胞激活所必需的。目标2
将确定TH1至TH2注射的平衡是否驱动单核细胞/巨噬细胞和pH表型
血吸虫-ph。 AIM 3将确定tsp1+单核细胞需要IMS释放CCL2/7/12
Scistosoma-ph招募。 AIM 4将识别与受试者PAH开发相关的血浆蛋白
与血吸虫病。通过开发和表征两个人群,将实现这种翻译目标
从巴西的4个临床中心招募的受试者:具有前体状态血吸虫病的受试者
肝病(SCHHSD),他们不太可能在超声心动图筛查的基础上进行PAH,
以及具有正确心脏导管插入式PAH的Schhsd的受试者。这些研究的完成将
导致了解先天和适应性免疫在Scistosoma-Pah的发展中的作用,以及
为完全新颖的方法创造机会诊断和潜在治疗这种疾病。我们建议
鉴定机械蛋白与血液中存在相关的机械蛋白,以支持高危的筛查
低资源地区的受试者。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
- DOI:10.1038/ncomms15494
- 发表时间:2017-05-30
- 期刊:
- 影响因子:16.6
- 作者:Kumar R;Mickael C;Kassa B;Gebreab L;Robinson JC;Koyanagi DE;Sanders L;Barthel L;Meadows C;Fox D;Irwin D;Li M;McKeon BA;Riddle S;Dale Brown R;Morgan LE;Evans CM;Hernandez-Saavedra D;Bandeira A;Maloney JP;Bull TM;Janssen WJ;Stenmark KR;Tuder RM;Graham BB
- 通讯作者:Graham BB
A retrospective study of schistosomiasis-associated pulmonary hypertension from an endemic area in Brazil.
巴西血吸虫病流行区与血吸虫病相关的肺动脉高压的回顾性研究。
- DOI:10.1016/j.ijcha.2019.100387
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Botoni,FernandoAntônio;Marinho,CarolinaCoimbra;Carvalho,ViniciusTostes;Mickael,ClaudiaS;Graham,BrianB
- 通讯作者:Graham,BrianB
Sexual Dimorphism of Dexamethasone as a Prophylactic Treatment in Pathologies Associated With Acute Hypobaric Hypoxia Exposure.
- DOI:10.3389/fphar.2022.873867
- 发表时间:2022
- 期刊:
- 影响因子:5.6
- 作者:Chanana, Neha;Palmo, Tsering;Sharma, Kavita;Kumar, Rahul;Shah, Bhushan;Mahajan, Sudhanshu;Palleda, Girish M.;Gupta, Mohit D.;Kukreti, Ritushree;Faruq, Mohammad;Thinlas, Tashi;Graham, Brian B.;Pasha, Qadar
- 通讯作者:Pasha, Qadar
Paclitaxel blocks Th2-mediated TGF-β activation in Schistosoma mansoni-induced pulmonary hypertension.
紫杉醇阻断 Th2 介导的 TGF-β 激活曼氏血吸虫诱导的肺动脉高压。
- DOI:10.1177/2045894018820813
- 发表时间:2019
- 期刊:
- 影响因子:2.6
- 作者:Kassa,Biruk;Mickael,Claudia;Kumar,Rahul;Sanders,Linda;Koyanagi,Dan;Hernandez-Saavedra,Daniel;Tuder,RubinM;Graham,BrianB
- 通讯作者:Graham,BrianB
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.
- DOI:10.1172/jci161077
- 发表时间:2022-05-16
- 期刊:
- 影响因子:15.9
- 作者:Bertero, Thomas;Lu, Yu;Annis, Sofia;Hale, Andrew;Bhat, Balkrishen;Saggar, Rajan;Saggar, Rajeev;Wallace, W. Dean;Ross, David J.;Vargas, Sara O.;Graham, Brian B.;Kumar, Rahul;Black, Stephen M.;Fratz, Sohrab;Fineman, Jeffrey R.;West, James D.;Haley, Kathleen J.;Waxman, Aaron B.;Chau, B. Nelson;Cottrill, Katherine A.;Chan, Stephen Y.
- 通讯作者:Chan, Stephen Y.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Barkley Graham其他文献
Brian Barkley Graham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Barkley Graham', 18)}}的其他基金
Screening for schistosomiasis-associated pulmonary arterial hypertension
血吸虫病相关肺动脉高压的筛查
- 批准号:
10742608 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
Determining the location and phenotype requirement of CD4 T cells in schistosomiasis pulmonary hypertension
确定血吸虫病肺动脉高压中 CD4 T 细胞的位置和表型要求
- 批准号:
10732723 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
Role of Complement-Driven Pulmonary Vascular Inflammation in PH
补体驱动的肺血管炎症在 PH 中的作用
- 批准号:
10686932 - 财政年份:2020
- 资助金额:
$ 8.25万 - 项目类别:
Role of Complement-Driven Pulmonary Vascular Inflammation in PH
补体驱动的肺血管炎症在 PH 中的作用
- 批准号:
10470736 - 财政年份:2020
- 资助金额:
$ 8.25万 - 项目类别:
Role of Complement-Driven Pulmonary Vascular Inflammation in PH
补体驱动的肺血管炎症在 PH 中的作用
- 批准号:
10224332 - 财政年份:2020
- 资助金额:
$ 8.25万 - 项目类别:
Investigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertension
研究血吸虫肺动脉高压临床前模型中的紫杉醇治疗
- 批准号:
9419493 - 财政年份:2017
- 资助金额:
$ 8.25万 - 项目类别:
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
血吸虫肺动脉高压中 CD4 T 细胞的激活、表型和功能
- 批准号:
10444970 - 财政年份:2016
- 资助金额:
$ 8.25万 - 项目类别:
Investigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertension
研究血吸虫肺动脉高压临床前模型中的紫杉醇治疗
- 批准号:
9751561 - 财政年份:2016
- 资助金额:
$ 8.25万 - 项目类别:
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
血吸虫肺动脉高压中 CD4 T 细胞的激活、表型和功能
- 批准号:
9217202 - 财政年份:2016
- 资助金额:
$ 8.25万 - 项目类别:
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
血吸虫肺动脉高压中 CD4 T 细胞的激活、表型和功能
- 批准号:
10685442 - 财政年份:2016
- 资助金额:
$ 8.25万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Reconfigurable 3D Origami Probes for Multi-modal Neural Interface
用于多模态神经接口的可重构 3D 折纸探针
- 批准号:
10738994 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
Bridging bench to bedside with aneurotechnology cross-development platform
通过神经技术交叉开发平台将工作台与床边桥接起来
- 批准号:
10640424 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
Outer hair cells and noise-induced hearing loss
外毛细胞和噪音引起的听力损失
- 批准号:
10862034 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
A wireless closed-loop sleep modulation system-on-chip
无线闭环睡眠调制片上系统
- 批准号:
10733872 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别:
Excessive lipid metabolism in T cell senescence and immunosuppression
T细胞衰老和免疫抑制中的过度脂质代谢
- 批准号:
10735675 - 财政年份:2023
- 资助金额:
$ 8.25万 - 项目类别: